• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 基因缺失促进低氧诱导的肺动脉高压和小鼠血管重构。

p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice.

机构信息

Third Department of Internal Medicine, University of Fukui, Fukui, Japan.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L753-61. doi: 10.1152/ajplung.00286.2010. Epub 2011 Feb 18.

DOI:10.1152/ajplung.00286.2010
PMID:21335523
Abstract

Chronic hypoxia induces pulmonary arterial remodeling, resulting in pulmonary hypertension and right ventricular hypertrophy. Hypoxia has been implicated as a physiological stimulus for p53 induction and hypoxia-inducible factor-1α (HIF-1α). However, the subcellular interactions between hypoxic exposure and expression of p53 and HIF-1α remain unclear. To examine the role of p53 and HIF-1α expression on hypoxia-induced pulmonary arterial remodeling, wild-type (WT) and p53 knockout (p53KO) mice were exposed to either normoxia or hypoxia for 8 wk. Following chronic hypoxia, both genotypes demonstrated elevated right ventricular pressures, right ventricular hypertrophy as measured by the ratio of the right ventricle to the left ventricle plus septum weights, and vascular remodeling. However, the right ventricular systolic pressures, the ratio of the right ventricle to the left ventricle plus septum weights, and the medial wall thickness of small vessels were significantly greater in the p53KO mice than in the WT mice. The p53KO mice had lower levels of p21 and miR34a expression, and higher levels of HIF-1α, VEGF, and PDGF expression than WT mice following chronic hypoxic exposure. This was associated with a higher proliferating cell nuclear antigen expression of pulmonary artery in p53KO mice. We conclude that p53 plays a critical role in the mitigation of hypoxia-induced small pulmonary arterial remodeling. By interacting with p21 and HIF-1α, p53 may suppress hypoxic pulmonary arterial remodeling and pulmonary arterial smooth muscle cell proliferation under hypoxia.

摘要

慢性缺氧可引起肺血管重塑,导致肺动脉高压和右心室肥厚。缺氧被认为是 p53 诱导和缺氧诱导因子-1α(HIF-1α)的生理刺激因素。然而,缺氧暴露与 p53 和 HIF-1α表达之间的亚细胞相互作用尚不清楚。为了研究 p53 和 HIF-1α表达在缺氧诱导的肺血管重塑中的作用,野生型(WT)和 p53 敲除(p53KO)小鼠分别暴露于常氧或缺氧环境 8 周。慢性缺氧后,两种基因型的右心室压力均升高,右心室肥厚(以右心室与左心室加室间隔重量的比值衡量)和血管重塑。然而,p53KO 小鼠的右心室收缩压、右心室与左心室加室间隔重量的比值以及小血管的中膜厚度均明显高于 WT 小鼠。慢性缺氧暴露后,p53KO 小鼠的 p21 和 miR34a 表达水平较低,而 HIF-1α、VEGF 和 PDGF 表达水平较高。这与 p53KO 小鼠肺动脉中增殖细胞核抗原表达较高有关。我们得出结论,p53 在减轻缺氧诱导的小肺血管重塑中起关键作用。通过与 p21 和 HIF-1α相互作用,p53 可能在缺氧下抑制缺氧性肺血管重塑和肺血管平滑肌细胞增殖。

相似文献

1
p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice.p53 基因缺失促进低氧诱导的肺动脉高压和小鼠血管重构。
Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L753-61. doi: 10.1152/ajplung.00286.2010. Epub 2011 Feb 18.
2
Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.血管平滑肌缺氧诱导因子-1α对低氧性肺动脉高压的调节作用。
Am J Respir Crit Care Med. 2014 Feb 1;189(3):314-24. doi: 10.1164/rccm.201302-0302OC.
3
Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia-induced Pulmonary Hypertension.低氧诱导因子在慢性低氧性肺动脉高压诱导的右心室功能和重构中的作用。
Am J Respir Cell Mol Biol. 2020 Nov;63(5):652-664. doi: 10.1165/rcmb.2020-0023OC.
4
Hypoxia-inducible factor-1 α deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension.髓系谱系中缺氧诱导因子-1α缺失可减轻缺氧诱导的肺动脉高压。
Physiol Rep. 2019 Apr;7(7):e14025. doi: 10.14814/phy2.14025.
5
Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.LR11缺失可减轻小鼠缺氧诱导的肺动脉平滑肌细胞增殖并伴有中膜增厚。
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1972-9. doi: 10.1161/ATVBAHA.116.307900. Epub 2016 Aug 4.
6
KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension.KLF5通过缺氧诱导因子-1α在缺氧性肺动脉高压中介导血管重塑。
Am J Physiol Lung Cell Mol Physiol. 2016 Feb 15;310(4):L299-310. doi: 10.1152/ajplung.00189.2015. Epub 2015 Dec 23.
7
Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.缺氧诱导因子-1α调节血管内皮生长因子在缺氧性肺动脉高压大鼠肺动脉中的作用。
Chin Med J (Engl). 2004 Jul;117(7):1023-8.
8
Absence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice.腺苷A2A受体缺失导致小鼠肺动脉高压并加剧肺血管重塑。
J Vasc Res. 2011;48(2):171-83. doi: 10.1159/000316935. Epub 2010 Oct 8.
9
IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.IL-33 通过上调血管内皮细胞中 HIF-1α 和 VEGF 的表达引发低氧性肺动脉高压中的血管重塑。
EBioMedicine. 2018 Jul;33:196-210. doi: 10.1016/j.ebiom.2018.06.003. Epub 2018 Jun 18.
10
Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.HIV 相关肺血管重构中的缺氧诱导因子-1α/血小板衍生生长因子轴。
Respir Res. 2011 Aug 5;12(1):103. doi: 10.1186/1465-9921-12-103.

引用本文的文献

1
Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators.通过机器学习和免疫浸润对肺动脉高压中与二硫键连接的细胞程序性坏死相关基因进行综合分析:聚焦USP32和ZNF655作为关键调节因子
PLoS One. 2025 Sep 9;20(9):e0330832. doi: 10.1371/journal.pone.0330832. eCollection 2025.
2
Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides.用netrin-1衍生、改良和改进的小肽对肺动脉高压进行新型且卓越的治疗。
Redox Biol. 2025 Jun 13;85:103710. doi: 10.1016/j.redox.2025.103710.
3
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.
肺动脉高压:分子机制与临床研究
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.
4
Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease.基于纳米载体的新兴基因治疗:心血管疾病的一种有前景的治疗选择及心脏瓣膜病的一种新策略
Int J Mol Sci. 2025 Feb 18;26(4):1743. doi: 10.3390/ijms26041743.
5
Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.骨骼肌 SIRT3 缺乏导致射血分数保留的心力衰竭相关肺动脉高压的肺血管重构。
Circulation. 2024 Sep 10;150(11):867-883. doi: 10.1161/CIRCULATIONAHA.124.068624. Epub 2024 May 28.
6
Biphasic regulation of miR-17∼92 transcription during hypoxia: roles of HIF1 and p53 hyperphosphorylation at ser15.低氧诱导 miR-17∼92 转录的双相调控:HIF1 和 p53 丝氨酸 15 过度磷酸化的作用。
Am J Physiol Lung Cell Mol Physiol. 2024 Jul 1;327(1):L102-L113. doi: 10.1152/ajplung.00127.2023. Epub 2024 Mar 19.
7
A hypothesis: Potential contributions of metals to the pathogenesis of pulmonary artery hypertension.假说:金属元素对肺动脉高压发病机制的潜在贡献。
Life Sci. 2024 Jan 1;336:122289. doi: 10.1016/j.lfs.2023.122289. Epub 2023 Nov 24.
8
Comprehensive analysis of mA methylomes in idiopathic pulmonary arterial hypertension.特发性肺动脉高压中 mA 甲基组的综合分析。
Epigenetics. 2023 Dec;18(1):2242225. doi: 10.1080/15592294.2023.2242225.
9
Transcription factors and potential therapeutic targets for pulmonary hypertension.肺动脉高压的转录因子及潜在治疗靶点
Front Cell Dev Biol. 2023 Mar 17;11:1132060. doi: 10.3389/fcell.2023.1132060. eCollection 2023.
10
A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3.p53-TLR3轴通过IRF3诱导BMPR2来改善肺动脉高压。
iScience. 2023 Jan 5;26(2):105935. doi: 10.1016/j.isci.2023.105935. eCollection 2023 Feb 17.